GENEVA, Aug. 14 -- ALEVIAN, INC. filed a patent application (US2026/013713) for “GDF11 BIOMARKERS, METHODS, AND COMPOSITIONS FOR TREATING STROKE”. With publication no. WO/2026/169642, here are the other details related to the patent application:
Kind: Initial Publication without ISR [A2]
IPC: A61K 38/18
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....